Docetaxel Injection
Product Images NDC 68083-401

This is a description of Docetaxel Injection, USP, which is a cytotoxic agent that is administered intravenously. The drug is packaged as a 1x16mL multi-dose vial, and users are advised to check concentration prior to preparation. The solution is ready to add to an infusion, and the package insert contains complete instructions for use. The dosage, handling, and storage information are also provided in the package insert. After first use, the solution is stable for up to 28 days when stored between 2° to 8°C and protected from light. The manufacturer is Gland Pharma Limited located in Andhra Pradesh, India.*

This is a description of Docetaxel Injection, USP, which is a cytotoxic agent that comes in a 20mg/2mL (10mg/mL) single-dose vial ready to add to an infusion solution for intravenous infusion only. There are instructions to check concentration prior to preparation, discard unused portions, and to see package insert for complete instructions, dosage information, and handling directions. It must be retained in the original package to protect from light, and stored at 20°C to 25°C (68°F to 77°F). The manufacturer is Giand Pharma Limited in Visakhapatnam, India.*

This is a description of a medication called Docetaxel Injection, USP, which is a cytotoxic agent used for intravenous infusion only. It is available in 1x8mL multi-dose vials, each containing 80 mg/8 ml of the medication. The medication is ready to be added to an infusion solution but needs to be checked for concentration prior to preparation. The package insert provides complete instructions for dosage information, directions for use, and handling. The medication should be stored between 20°C to 25°C (68°F to 77°F) and must be retained in the original package to protect it from light. Following the first use, the medication is stable for up to 28 days when stored at 2°C to 8°C (36°F to 46°F) and kept out of reach of children. The medication is manufactured by Gland Pharma Limited from Andhra Pradesh, India.*

This is a description of Docetaxel Injection, USP, a multi-dose vial prescription-only medication used for intravenous infusion only. It contains 10mg of Docetaxel Anhydrous USP per mL, and a typical dosage can be found in the package insert. The medication must be stored at 20-25°C in a protected area devoid of light. The manufacture of this medication is Gland Pharma Limited out of India, and it is a cytotoxic agent. The text contains no information on how to use the medication.*

2mL single-dose vial of Docetaxel Injection, USP with a concentration of 20mg/2mL (10mg/mL). This is a cytotoxic agent intended for intravenous infusion only. Any unused portion should be discarded. It is ready to be added to the infusion solution, but concentration should be checked prior to preparation. The package insert contains complete instructions. This product was manufactured by Gland Pharma Limited in India and should be stored at temperatures between 20 and 25°C.*

This is a description of Docetaxel Injection, a cytotoxic agent drug that is used for intravenous infusion only. Each multi-dose vial contains 80mg/8mL (10mg/ml) of Docetaxel, along with other ingredients. The drug must be checked for concentration before administration and should be stored between 20-25°C, protected from light. The usual dosage should be seen in the insert. The manufacturer of this drug is Gland Pharma Limited in India. The text also includes the NDC code and other important information.*

The text describes a graph showing the cumulative probability of Overall Survival over a period of time (measured in months). The Log-rank p-value is 0.010. The x-axis corresponds to the survival time in months and the y-axis corresponds to the cumulative probability. The graph shows the probability of survival for a certain group of subjects (represented by the label "Fos5" and "Fo.2") during the study period.*

This is a graph showing the cumulative probability of survival over a period of 15 months. The x-axis shows the survival time in months, while the y-axis shows the cumulative probability of survival. The graph also indicates that the log-rank p-value is 0.13.*

This appears to be a chart showing survival probabilities over a period of time. The X-axis represents survival time in months, with figures of 9, 12, 15, and 18 months being marked. The Y-axis contains survival probability figures of 2%, 2%, 27%, and 30%.*

This is a visualization of disease-free survival probability over time for a certain medical condition represented by a K-M curve. The x-axis shows the duration of disease-free survival time in months while the y-axis shows the probability percentage. It is not clear what medical condition is being examined.*